Memantine in Patients With Chronic Glaucoma

Study Identifier
192944-005
CT.gov Identifier
NCT00168350
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
    • Study Drug
  • memantine
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18 - 82 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion Criteria: * glaucoma damage on examination of visual field and optic disc * good visual acuity (with glasses if needed)

    Protocol Summary

    Randomized double-masked clinical trial of memantine in patients with glaucoma

    Study Locations

    No locations found.